DementiaFCSRT-TNCT05756231
Cultural and Linguistic Adaptation and Normative Study of the Turkish Version of the Free and Cued Selective Reminding Test: 16-Word Version (FCSRT-T)
A study testing SIHT-16 in people with Dementia and Memory Impairment, run by Istanbul University at 1 site in Turkey (Türkiye).
Trial summary
An Adaptation Study of Free and Cued Selective Reminding Test in Turkish Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Dementia, Memory Impairment
- What is being tested?
- SIHT-16
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 285 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 5 Jan 2020to 2 Apr 2025
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- having memory complaints
- demanding clinical consultation for the memory complaint
Who cannot join
- vascular pathology
- extrapyramidal findings
- psychiatric illness
- epilepsy
- cognition affecting drug use
Trial locations and contacts
1 site in 1 country.
About this study
An Adaptation Study of Free and Cued Selective Reminding Test in Turkish
Read the detailed description
As very commonly used for objectifying Alzheimer Disease memory deficits, an adaptive selection of word choices are done for the use of free and cued selective reminding test (FCSRT) procedure in Turkish population. In this study the validity and reliability of the test to measure memory deficits in persons with memory complaints will be discussed.
- Conditions
- Dementia, Memory Impairment
- Being tested
- SIHT-16
- Keywords
- Alzheimer Disease, Memory Complaint, Memory, Dementia, Free and Cued Selective Reminding Test, Adaptation, Validity
- Medical subject headings
- Dementia, Memory Disorders, Alzheimer Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SIHT-16Behavioural
a pencil-paper assessment tool.
| Study group | Role | What they receive |
|---|---|---|
| Turkish Adaptation Study of Free and Cued Selective Reminding Test (SIHT-16) | Experimental | Outcomes of Turkish adaptation of Free and cued selective reminding test (SIHT-16) is compared with memory and non-memory test in three alternative lists: a,b, and c parallel lists. The participants are assessed in neurological diagnosis routine. Receives: Behavioral: SIHT-16 |
What is being measured
The primary outcome is the main question the study is designed to answer.
Validity of translation
Variances of answers given to each form will be compared to each other to know if they are similar or different.
Measured: once
Factor Analyses
Factor Analyses must be conducted to redefine the weight of each item on measuring memory deficits to be sure that turkish words version is similar to original factor weights.
Measured: once
Validity of the ability of the measure to objectify the memory deficit in dementia
Test measures must be sensitive enough to objectify a memory deficits even in early stages of dementia. The scores of memory test in early and late stages of dementia will be compared to see if they are different. It's expected to be different.
Measured: once
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Mar 2023
- Study start5 Jan 2020
- Primary completion26 Dec 2024
- Study completion2 Apr 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DementiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 285 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jbid DURSUN UNCU, Istanbul University
- Investigators
- İ. Hakan Gürvit, Prof. MD., Study director, Istanbul University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05756231
- Sponsor's protocol ID
- 2019/778
- Acronym
- FCSRT-T
- Status last verified
- Apr 2025
- First submitted
- 26 Jan 2023
- Last updated
- 4 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No